| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.44 | 0.05 |